Voyageur Pharmaceuticals Ltd (VM : TSX-V)
Common Stock
$0.15
CAD
+0.01 (7.14%)
Last updated: 2026-07-21
VM
Voyageur Pharmaceuticals Ltd
WealthAwesomePerformance
1 Day
+7.14%
1 Week
+7.14%
1 Month
+30.43%
YTD
-11.76%
Key Statistics
Market Cap
$26.02M
52W High
$0.20
52W Low
$0.07
P/E Ratio
-
50 Day MA
$0.11
200 Day MA
$0.14
Beta
0.31
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/21/2026 | $0.14 | $0.15 | $0.14 | $0.15 | $0.15 | 508,432 |
| 7/20/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 84,680 |
| 7/17/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 111,403 |
| 7/16/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 10,000 |
| 7/15/2026 | $0.14 | $0.14 | $0.13 | $0.14 | $0.14 | 552,000 |
| 7/14/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 50,500 |
| 7/13/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 39,884 |
| 7/9/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 25,500 |
| 7/8/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 19,637 |
| 7/7/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 137,500 |
Analyst Price Targets
Based on analyst covering VM
Wall Street analysts forecast VM stock price to rise 266.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.55
+266.7% Upside
Current Price
C$0.15
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VM's historical volatility
30-Day Vol
112.9%
Annualized
90-Day Vol
119.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.18
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.16 | C$0.11 โ C$0.24 |
| 60 trading days | C$0.17 | C$0.10 โ C$0.29 |
| 90 trading days | C$0.18 | C$0.09 โ C$0.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $30,959
- EBITDA
- $-2.81M
- Profit Margin
- 0.00%
- ROE (TTM)
- -361.91%
- EPS (Diluted)
- -0.01
- Book Value
- 0.00
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About VM
Articles Featuring VM.V
Latest articles and analysis covering VM.V
Why Voyageur Pharmaceuticals Ltd stock surged yesterday
Voyageur Pharmaceuticals Ltd stock surged 7.14% yesterday, marking a significant gain as the company begins commercial shipments of its barium contrast products.
Why Voyageur Pharmaceuticals Ltd stock is skyrocketing today
Voyageur Pharmaceuticals Ltd's stock has jumped by 7.69% as the company begins its first commercial shipments of barium contrast products, marking a pivotal moment in its development.
Why Voyageur Pharmaceuticals Ltd stock is skyrocketing today
Voyageur Pharmaceuticals Ltd has engaged Fluor Corporation to advance feasibility studies for iodine production and integrated contrast drug manufacturing, leading to a 27.27% stock increase.
Why Voyageur Pharmaceuticals Ltd stock is rising today
Voyageur Pharmaceuticals Ltd is experiencing a surge in stock price following its engagement with Fluor Corporation to advance feasibility studies for iodine production and integrated contrast drug manufacturing. This strategic move aims to enhance its supply chain and production capabilities in the medical imaging market.
Why Voyageur Pharmaceuticals Ltd stock is rising today
Voyageur Pharmaceuticals Ltd's stock has risen by 4.76% today, fueled by the company's engagement with Fluor Corporation to advance feasibility studies for iodine production. This strategic move positions Voyageur to potentially lead the North American market for contrast media.
